These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases]. Malling HJ Wien Med Wochenschr; 1999; 149(14-15):410-4. PubMed ID: 10584284 [TBL] [Abstract][Full Text] [Related]
7. What should drive the choice of allergen for immunotherapy in polysensitized patients? Ciprandi G; Incorvaia C; Puccinelli P; Dell'Albani I; Frati F Ann Allergy Asthma Immunol; 2012 Aug; 109(2):148-9. PubMed ID: 22840259 [No Abstract] [Full Text] [Related]
8. Instructions and consent forms for subcutaneous allergen immunotherapy. Cox L; Lockey RF Clin Allergy Immunol; 2008; 21():499-525. PubMed ID: 18828526 [No Abstract] [Full Text] [Related]
9. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines. Mascarell L; Van Overtvelt L; Moingeon P Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145 [TBL] [Abstract][Full Text] [Related]
11. Specific immunotherapy with allergen mixes: what is the evidence? Nelson HS Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):549-53. PubMed ID: 19745727 [TBL] [Abstract][Full Text] [Related]
13. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280 [TBL] [Abstract][Full Text] [Related]
14. Experimental forms of allergen immunotherapy with modified allergens and adjuvants. Mohapatra SS; San-Juan-Vergara H; Wopfner N; Ferreira F Clin Allergy Immunol; 2008; 21():393-413. PubMed ID: 18828519 [No Abstract] [Full Text] [Related]
15. Adjuvants and vector systems for allergy vaccines. Moingeon P; Lombardi V; Saint-Lu N; Tourdot S; Bodo V; Mascarell L Immunol Allergy Clin North Am; 2011 May; 31(2):407-19, xii. PubMed ID: 21530828 [TBL] [Abstract][Full Text] [Related]
16. [The mechanisms of allergen-specific immunotherapy more clear]. Rak S Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1935-7. PubMed ID: 18681375 [No Abstract] [Full Text] [Related]
17. Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases. Malling HJ; Bousquet J Clin Allergy Immunol; 2008; 21():343-58. PubMed ID: 18828516 [No Abstract] [Full Text] [Related]
18. [The progress on allergen-specific immunotherapy for bronchial asthma]. Liu HY; Xie LY; Zhou LF Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):450-4. PubMed ID: 24103210 [No Abstract] [Full Text] [Related]
19. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy. Crameri R Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139 [TBL] [Abstract][Full Text] [Related]
20. Modification of the innate immune function of dendritic cells by allergen-specific immunotherapy. Bellinghausen I Clin Exp Allergy; 2010 Jan; 40(1):12-4. PubMed ID: 20205693 [No Abstract] [Full Text] [Related] [Next] [New Search]